Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2000
12/07/2000WO2000073269A2 Nicotine receptor ligands
12/07/2000DE19925593A1 Substituierte 2-Aryl-1,2,4-triazin-3,5-di(thi)one Substituted 2-aryl-1,2,4-triazine-3,5-di (thi) ones
12/07/2000CA2370141A1 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
12/06/2000EP1057826A1 Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them
12/06/2000EP1057819A1 Phthalazine derivatives and remedies for erectile dysfunction
12/06/2000EP1057814A1 Tetrahydrobenzindole derivatives
12/06/2000EP1057812A1 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
12/06/2000EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/06/2000EP1056725A1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas
12/06/2000EP1056724A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
12/06/2000EP1056719A2 Inhibitors of phospholipase enzymes
12/06/2000CN1275979A Isoquinolines as urokinase inhibitors
12/06/2000CN1059210C Process for preparation of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrbenz [cd] indoles and acid additive salt used as medicine
12/05/2000US6156782 Parasiticidal compounds
12/05/2000US6156781 Antiinflammatory agents for skin
12/05/2000US6156774 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
12/05/2000US6156761 Substituted tetralone derivatives for enhancing cognition
11/2000
11/30/2000WO2000071572A1 Substituted beta-alanine derivatives as cell adhesion inhibitors
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071536A1 Heteroaryloxypyrimidine insecticides and acaricides
11/30/2000WO2000071533A2 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
11/30/2000WO2000071532A1 Heterocyclic derivatives useful as anticancer agents
11/30/2000WO2000071522A1 Benzimidazole derivatives and their use as methionyl t-rna synthetase inhibitors
11/30/2000WO2000071519A2 Immunopotentiator agents
11/30/2000WO2000071518A2 Heterocyclic analgesic compounds and their use
11/30/2000WO2000071517A1 Phenoxypropylamine compounds
11/30/2000WO2000071171A2 Sigma-1 ligands for determining carcinoma proliferative status
11/30/2000WO2000071120A1 Antibacterial compounds
11/30/2000WO2000047559A3 5-ht1f agonists
11/30/2000WO2000046199A3 Indole derivatives as anti-inflammation agents
11/30/2000DE19924668A1 Substituierte alpha-Phenyl-beta-Ketosulfone Substituted alpha-phenyl-beta-ketosulfones
11/30/2000CA2716369A1 Phenoxypropylamine compounds
11/30/2000CA2374775A1 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
11/30/2000CA2372887A1 Heterocyclic analgesic compounds and their use
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/29/2000EP1055672A1 1,4-dihydropyridine derivatives
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054882A1 Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000CN1275124A Phthalazine derivatives and remedies for erectile dysfunction
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/29/2000CN1274724A Prepn. of 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-asymmetric indacene
11/29/2000CN1274719A Process for preparation of substituted pyridine compound
11/29/2000CN1274718A Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same
11/28/2000US6153761 An intermediates for preparing herbicides and/or fungicides
11/28/2000US6153759 Herbicide comprising a 5-membered or 6-membered heterocyclic, saturated or unsaturated radical containing one to three hetero atoms selected from the group consisting of oxygen, sulfur and nitrogen
11/28/2000US6153642 Useful as antineoplastic and antiviral agents
11/28/2000US6153641 Pharmaceutically active compounds
11/28/2000US6153640 For treating depression, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse or anxiety
11/28/2000US6153613 2,3-diketopiperazine derivatives or their salts
11/28/2000CA2173788C Substituted thiophene derivative and agricultural and horticultural fungicide containing the same as active ingredient
11/23/2000WO2000069855A2 Furanone derivatives as inhibitors of cathepsin s
11/23/2000WO2000069854A1 Substituted thienocycloalk(en)ylamino-1,3,5-triazine
11/23/2000WO2000069853A1 Azole compounds and herbicide compositions
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069842A1 Benzofuranylsulfonates
11/23/2000WO2000069834A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000013681A3 4-quinolinemethanol derivatives as purine receptor antagonists (i)
11/23/2000CA2374559A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000CA2374297A1 Furanone derivatives as inhibitors of cathepsin s
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/23/2000CA2373666A1 Benzofuranylsulfonates
11/23/2000CA2373607A1 Cyclic amine derivatives and their uses
11/23/2000CA2373518A1 Azole compounds and herbicide compositions
11/23/2000CA2373500A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000CA2372617A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/23/2000CA2372426A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/22/2000EP1054005A1 Sulfonamide derivatives, process for producing the same and utilization thereof
11/22/2000EP1054004A1 Novel pyrimidine-5-carboxamide derivatives
11/22/2000EP1053230A1 Triazine antiviral compounds
11/22/2000EP1053224A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
11/22/2000EP1052992A1 Cyclic amine modulators of chemokine receptor activity
11/22/2000EP0827502B1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
11/22/2000EP0736012B1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
11/22/2000CN1274357A Antipsychotic substituted piperidine derivatives
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors
11/22/2000CN1058714C Method of preparing metal alkoxides
11/22/2000CN1058709C Amide compounds for medical treatment
11/21/2000US6150536 Dye doped organic-inorganic hybrid materials
11/21/2000US6150526 Piperidine derivative having renin inhibiting activity
11/21/2000US6150394 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
11/21/2000US6150393 N-(3-(4-bromo-1-methylpyrazol-3-yl)phenyl)(phenylmethylamino) -carboxamide modifier of activity of the serotonin 5-ht 2a; cns, gastrointestinal and cardiovascular disorders; antiinflammatory agents; side effect reduction
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150375 Inhibitors of both of the human 5ar isozymes; benign prostate hyperplasia, male pattern baldness, acne vulgaris, seborrhea, androgenic alopecia, hirsutism and prostate cancer; blocks the conversion of testosterone to 5-alpha-dihydrotestosterone
11/21/2000US6150372 Immunoinflammatory and autoimmune diseases; blocking intracellular signal transduction and activation of transcription factors; kinase inhibitors; antiarthritic, ischemic agents, multiple sclerosis, transplant rejection
11/21/2000US6150370 1,3-dinitrocyclic compound treats numerous diseases caused by undesired metalloprotease activity, such as tumor metastasis, osteoarthritis, rheumatoid arthritis, skin inflammation, ulcerations, and periodontitis
11/21/2000US6150362 Administering 1,3,5-substituted triazine compounds to the patient suffering from angiogenic diseases
11/21/2000US6150356 Potassium channel inhibitors and method
11/21/2000US6150352 Antagonists of gonadotropin releasing hormone
11/16/2000WO2000068226A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds
11/16/2000WO2000068213A1 Substituted bicyclic compounds
11/16/2000WO2000068206A1 Heterocyclically substituted benzimidazoles, the production and application thereof
1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 523